Action Observation Training for Upper Limb Rehabilitation in Stroke Patients

May 24, 2022 updated by: Sofia Straudi, University Hospital of Ferrara

Neuro-rehabilitation of Upper Limb Stroke Patients Through Motor Resonance and Mirror Neurons

The purpose of this study is to assess the changes in physiological parameters and clinical scales resulting from treatment with AOT (action observation training) in subjects with subacute stroke. Furthermore, this study assess the perception of applicability and satisfaction degree for this kind of treatments.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

After being informed about the study, all patients give written informed consent and will undergo a 1-week screening period to determine eligibility for study entry. Patient who meet the eligibility requirements will be given clinical and instrumental assessments before the start of treatment (T0) after 3 weeks (T1), at the end of the treatment (T2) and after 6 months (T3). A training program of 4 weeks including 250 videos of every day actions has been developed. Videos includes transitive and intransitive actions. Each week has a five day program, each day is divided in three sessions, in each session there are observation and imitation and attentional questions. AOT is always performed in conjunction with the conventional rehabilitation program.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Emilia Romagna
      • Ferrara, Emilia Romagna, Italy, 44124
        • Sofia Straudi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Should had experienced first ever ischemic or haemorrhagic stroke
  • Fugl-Meyer Assessment < 55
  • normal or corrected to normal visual acuity

Exclusion Criteria:

  • presence of severe neuropsychological disorders
  • medical conditions likely to interfere with the ability to safely complete the study protocol
  • pain in the upper limb assessed with the Visual Analogue Scale (VAS)> 7
  • intracranial metal implants
  • history of seizures or epilepsy
  • severe cardiopulmonary, renal, and hepatic diseases
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Action observation training for the upper limb rehabilitation
Neurorehabilitation training for the upper limb using AOT consists of watching videos related to every day actions. The subjects will be asked to reproduce, as accurately as possible, the actions proposed by the system, that will record their execution. In order to keep high motivation and participation in activities, simple games of skill will also be created that will involve the patient on both the motor and cognitive side. The training program includes 250 videos of every day transitive and intransitive actions: 20 consecutive sessions of 1 hour, five times a week over four weeks.

Integration of four main tools:

  • PATIENT INTERFACE, which has been implemented to present stimuli with a user friendly interface, with personalized menu and with the possibility to manage the training program; user personal page containing user information and history of activities with daily performance are stored too.
  • MOCAP during action imitation will be recorded using MindMotion infrared camera to capture the trunk movement while an electromagnetic system (Trackstar from NDI) will be used to record fingers fine movements.
  • EEG data will be collected during video observation using an Enobio wireless system integrated with the platform.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl-Meyer Assessment Upper Extremity between four time points
Time Frame: Baseline, week 3, week 4, after 6 months
Scale that assess the sensorimotor impairment in individuals who have had stroke.
Baseline, week 3, week 4, after 6 months
Change in Barthel Index between four time points
Time Frame: Baseline, week 3, week 4,after 6 months
Scale that measures disability or dependence in activities of daily living in stroke patients.
Baseline, week 3, week 4,after 6 months
Change in Box and Block Test between four time points
Time Frame: Baseline, week 3, week 4,after 6 months
To assess unilateral gross manual dexterity
Baseline, week 3, week 4,after 6 months
Change in Modified Ashworth Scale between four time points
Time Frame: Baseline, week 3, week 4,after 6 months
To measure spasticity. It consists of a 5-point nominal scale using subjective clinical assessments of tone ranging from 0 - 'No increases in tone' to 4 - 'Limb rigid in flexion or extension [abduction/adduction]'. An additional grade is added (1+) for the MAS to indicate resistance in the movement.
Baseline, week 3, week 4,after 6 months
Change in Visual Analogue Scale between four time points
Time Frame: Baseline , week 3, week 4,after 6 months
Scale that consists of a straight line with the endpoints defining extreme limits such as 'no pain at all' and 'pain as bad as it could be'. The length of the line is 10-cm. Measurements from the starting point (left end) of the scale to the patients' marks are recorded in centimeters and are interpreted as their pain.
Baseline , week 3, week 4,after 6 months
Electroencephalography power in alpha band
Time Frame: Up to 1 month
EEG data will be recorded to test presence of particular changes in brain activity in during AOT training. In particular plasticity and mu rhythm desynchronization will be investigated.
Up to 1 month
Motion Capture (MOCAP) recordings
Time Frame: Up to 1 month
Kinematic data of trunk and affected hand will be recorded during subject imitations and will be analysed to assess any improvements.
Up to 1 month
Change in Oxford Cognitive Screen between two time points
Time Frame: Baseline and week 4
is a stroke-specific cognitive screen
Baseline and week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Applicability perception and satisfaction degree of the proposed treatment
Time Frame: At week 4
self-report questionnaire using a 5 point Likert scale (1 - Strongly disagree; 5 - Strongly agree). Higher score indicates greater satisfaction with the treatment.
At week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Luciano Fadiga, MD, PhD, Section of Human Physiology, University of Ferrara (Ferrara, Italy)
  • Principal Investigator: Sofia Straudi, MD, PhD, Department of Neuroscience and Rehabilitation, University Hospital of Ferrara (Ferrara, Italy)
  • Principal Investigator: Thierry Pozzo, PhD, IIT; Istituto Italiano di Tecnologia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2020

Primary Completion (Actual)

December 9, 2021

Study Completion (Actual)

December 9, 2021

Study Registration Dates

First Submitted

October 29, 2020

First Submitted That Met QC Criteria

November 6, 2020

First Posted (Actual)

November 9, 2020

Study Record Updates

Last Update Posted (Actual)

May 25, 2022

Last Update Submitted That Met QC Criteria

May 24, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke Rehabilitation

Clinical Trials on Action observation training

3
Subscribe